The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe

被引:45
作者
Bielecka-Dabrowa A. [1 ]
Aronow W.S. [2 ]
Rysz J. [3 ]
Banach M. [1 ]
机构
[1] Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, 90-549 Lodz
[2] Department of Medicine, New York Medical College, Valhalla, NY
[3] Department of Nephrology, Hypertension and Family Medicine, Chair of Nephrology and Hypertension, Medical University of Lodz, Lodz
关键词
Eastern Europe; Epidemiology; Hypertension;
D O I
10.1007/s12170-010-0152-2
中图分类号
学科分类号
摘要
Hypertension is a progressive cardiovascular syndrome that arises from many differing, but interrelated, etiologies. Hypertension is the most prevalent cardiovascular disorder, affecting 20% to 50% of the adult population in developed countries. Arterial hypertension is a major risk factor for cardiovascular diseases and death. Epidemiologic data have shown that control of hypertension is achieved in only a small percentage of hypertensive patients. Findings from the World Health Organization project Monitoring Trends and Determinants in Cardiovascular Diseases (MONICA) showed a remarkably high prevalence (about 65%) of hypertension in Eastern Europeans. There is virtually no difference however, between the success rate in controlling hypertension when comparing Eastern and Western European populations. Diagnosing hypertension depends on both population awareness of the dangers of hypertension and medical interventions aimed at the detecting elevated blood pressure, even in asymptomatic patients. Medical compliance with guidelines for the treatment of hypertension is variable throughout Eastern Europe. Prevalence of hypertension increases with age, and the management of hypertension in elderly is a significant problem. The treatment of hypertension demands a comprehensive approach to the patient with regard to cardiovascular risk and individualization of hypertensive therapy. © 2010 The Author(s).
引用
收藏
页码:174 / 179
页数:5
相关论文
共 55 条
[1]  
ASH Panel Proposes New Hypertension Definition, 2, pp. 1-7, (2005)
[2]  
Decline in deaths from heart disease and stroke-United States, 1990-1999, Jama, 282, pp. 724-726, (1999)
[3]  
Mancia G., Grassi G., The new European Society of Hypertension/European Society of Cardiology (ESH/ESC) Guidelines, Ther Adv Cardiovasc Dis., 2, 1, pp. 5-12, (2008)
[4]  
Subcommittee G., World Health Organization-International Society of Hypertension Guidelines for the management of hypertension, J Hypertens, 17, pp. 151-183, (1999)
[5]  
Chobanian A.V., Bakris G.L., Black H.R., Et al., Seventh report of the Joint National Committee on Prevention, Evaluation, and Treatment of High Blood Pressure, Hypertension, 42, pp. 1206-1252, (2003)
[6]  
Mancia G., Laurent S., Agabiti-Rosei E., Et al., Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document, J Hypertens, 27, pp. 2121-2158, (2009)
[7]  
Marques-Vidal P., Tuomilehto J., Hypertens awareness, treatment and control in the community: is the "rule of halves" still valid?, J Hum Hypertens, 11, pp. 213-220, (1997)
[8]  
Mancia G., Sega R., Milesi C., Cesana S., Zanchetti A., Blood pressure control in the hypertensive population, Lancet, 349, pp. 454-457, (1997)
[9]  
MacMahon S., Peto R., Cutler J., Et al., Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias, Lancet, 335, pp. 765-774, (1990)
[10]  
Kannel W.B., Blood pressure as a cardiovascular risk factor: prevention and treatment, Jama, 275, pp. 1571-1576, (1996)